A study of more than 21,000 average risk patients at 186 sites across the U.S., led by Regenstrief Institute and Indiana University School of Medicine research scientist Thomas Imperiale, M.D., has ...

A colonoscopy is recommended every decade for people over 45. The screening is used to detect colon cancer. But roughly 40% of eligible Americans don't get a colonoscopy, often because they don't want ...

VANCOUVER, British Columbia -- The novel multitarget stool RNA test (ColoSense) showed high sensitivity for detecting colorectal neoplasia among adults ages 45 and older, according to the phase III ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

In a real-world randomized study, inviting individuals to undergo combined Helicobacter pylori stool antigen testing and ...

Roughly 10% of fecal immunochemical tests (FIT) used for colorectal cancer (CRC) screening by a safety-net health system contained unsatisfactory samples that could not be processed. And fewer than ...

Researchers found collecting two samples during fecal immunochemical tests can improve diagnostic yield without affecting patients’ attendance to scheduled tests, according to a study published in ...

Q: My doctor always encourages me to do a colonoscopy for colorectal cancer screening. But I have friends who just do a stool test at home, which seems easier. Why should I go through the hassle of a ...

Please provide your email address to receive an email when new articles are posted on . Males, African Americans and people with Medicaid are more likely to submit an unsatisfactory sample. Less than ...

INDIANAPOLIS -- A study of more than 21,000 average risk patients at 186 sites across the U.S., led by Regenstrief Institute and Indiana University School of Medicine research scientist Thomas ...